Clinical and biochemical parameters were compared between patients with non-polycystic genetic kidney diseases with and without UMOD mutations (Table 4), and between ADTKD patients with and without UMOD mutations (Table 5). This evidence concerns the gene UMOD and autosomal dominant medullary cystic kidney disease with or without hyperuricemia.